Hey, it's iuhasbeenloser. After your great HEB call at your buy at 65 cents that stock has really taken off. Oh wait, it's at 21 cents. We won't worry because I'm sure you'll make it back with profit on top. You are a stock market guru. Every trading house must be beating down your door to hire you. Loser. Go home and play Monopoly.
it went great! Thanks for asking! I can't remember exactly but I sold somewhere in the 1.40 range after the stock more than doubled, up to 1.90+ and I sold on the second mini run up to 1.40... buy ins in the .70's...here is what IBIO is up to now...
In 2012, GE Healthcare announced a global alliance with iBio, Inc. (IBIO). iBio provides product solutions and technology for both proprietary and biosimilar products. iBio offers a unique iBioLaunch platform, which is used for development and production of biologics in unmodified green plants. iBioLaunch uses the transient gene expression for the production. Another platform offered by iBioLaunch is the iBioModulator, which is used for providing a significant improvement in vaccine products. It enables the product with higher potency and greater duration of effect.
Recently, the GE Alliance, the alliance between GE Healthcare and iBio has been awarded the contract to design a new plant based manufacturing facility in Brazil. This facility will be designed for Bio-Manguinhos/Fiocruz, which is a techno-scientific unit of the Oswaldo Cruz Foundation (Fiocruz). Fiocruz is an institution of the Brazilian Ministry of Health.
Commenting on the latest development, Olivier Loeillot, General Manager of Enterprise Solutions at GE Healthcare said : "Vaccines are vital in the fight against global disease and we're pleased to be working with Bio-Manguinhos/Fiocruz on this important project. GE Healthcare's global capabilities and industry-leading expertise in biopharmaceutical manufacturing technologies, coupled with iBio's innovative technology and experience in plant-based protein expression, provide a solid foundation for this design project. By working closely with the team at Bio-Manguinhos/Fiocruz we will together design a state-of-the-art, technologically-advanced facility that's ready to meet the vaccine needs of tomorrow."
The alliance between GE Healthcare and iBio is in sync with GE's new initiative -healthymagination.
I feel the same way, but I've felt that way since the start of the year. Did go from a nickel to a dime, but hasn't done doodoo since. Was looking for a run to at least .15, but if it doesn't happen before the end of May it will probably be a long boring year.